Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$80.9M |
| 2 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$66M |
| 3 |
Merck
MRK
|
+$63.3M |
| 4 |
Procter & Gamble
PG
|
+$58.4M |
| 5 |
IBM
IBM
|
+$54.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$178M |
| 2 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$73.8M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$67.3M |
| 4 |
CSC
Computer Sciences
CSC
|
+$61.8M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$44.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.35% |
| 2 | Technology | 13.54% |
| 3 | Financials | 12.88% |
| 4 | Industrials | 10.76% |
| 5 | Consumer Staples | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
AtriCure
ATRC
$2.91B
| $652K | ﹤0.01% |
46,100
| – | – |
|
2502
Natera
NTRA
$49.8B
| $650K | ﹤0.01% |
53,850
+27,720
| +106% | +$308K |
|
|
BHBK
2503
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $648K | ﹤0.01% |
43,900
| – | – |
|
2504
The Bancorp
TBBK
$2.07B
| $643K | ﹤0.01% |
106,773
+1,806
| +2% | +$10.9K |
|
2505
eHealth
EHTH
$27.5M
| $642K | ﹤0.01% |
45,725
+714
| +2% | +$8.67K |
|
2506
Corcept Therapeutics
CORT
$12.1B
| $639K | ﹤0.01% |
116,906
+30,400
| +35% | +$158K |
|
|
TVIA
2507
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
| $639K | ﹤0.01% |
+243,651
| New | +$566K |
|
2508
Hovnanian Enterprises
HOV
$692M
| $637K | ﹤0.01% |
15,150
+221
| +1% | +$9.18K |
|
|
GBL
2509
DELISTED
GAMCO Investors, Inc.
GBL
| $637K | ﹤0.01% |
19,423
-2,646
| -12% | -$96.8K |
|
|
NXH
2510
Neighborhood Intelligence Inc
NXH
$324M
| $636K | ﹤0.01% |
52,520
+1,062
| +2% | +$12.7K |
|
|
BEAT
2511
DELISTED
BioTelemetry, Inc.
BEAT
| $631K | ﹤0.01% |
38,700
| – | – |
|
|
SQBG
2512
DELISTED
Sequential Brands Group, Inc.
SQBG
| $630K | ﹤0.01% |
1,973
| – | – |
|
|
ENZ
2513
DELISTED
Enzo Biochem, Inc.
ENZ
| $628K | ﹤0.01% |
105,081
+61,100
| +139% | +$339K |
|
|
RNET
2514
DELISTED
RigNet, Inc.
RNET
| $625K | ﹤0.01% |
46,640
-13,867
| -23% | -$186K |
|
2515
Kratos Defense & Security Solutions
KTOS
$8.93B
| $621K | ﹤0.01% |
151,398
+2,604
| +2% | +$11.8K |
|
2516
Limoneira
LMNR
$229M
| $618K | ﹤0.01% |
35,043
+462
| +1% | +$7.68K |
|
2517
Alarm.com
ALRM
$2.72B
| $617K | ﹤0.01% |
24,050
+420
| +2% | +$9.45K |
|
|
CMCT
2518
Creative Media & Community Trust
CMCT
$8.24M
| $617K | ﹤0.01% |
1
| – | – |
|
2519
Anterix
ATEX
$1.49B
| $614K | ﹤0.01% |
28,698
-6,780
| -19% | -$214K |
|
|
EVDY
2520
DELISTED
Everyday Health, Inc.
EVDY
| $614K | ﹤0.01% |
77,877
+17,834
| +30% | +$114K |
|
2521
Peoples Bancorp
PEBO
$1.42B
| $611K | ﹤0.01% |
28,000
| – | – |
|
2522
Utah Medical Products
UTMD
$236M
| $611K | ﹤0.01% |
9,691
| – | – |
|
|
OTIC
2523
DELISTED
Otonomy, Inc.
OTIC
| $611K | ﹤0.01% |
38,439
+8,300
| +28% | +$124K |
|
|
HSKA
2524
DELISTED
Heska Corp
HSKA
| $611K | ﹤0.01% |
16,417
| – | – |
|
2525
Franklin Covey
FC
$201M
| $609K | ﹤0.01% |
39,694
+714
| +2% | +$11K |
|
Similar funds
Charles Schwab's Q2 2016 Portfolio in Review
As of Q2 2016, Charles Schwab held 3,241 positions worth $80B, up 5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab's Q2 2016 filing shows 178 new, 2,105 increased, 536 reduced and 137 closed positions. Its largest new stake was S&P Global: 753,915 shares worth $80.9M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- Charles Schwab's largest Q2 2016 buy was S&P Global: 753,915 shares worth $80.9M.
- Charles Schwab added most to Merck in Q2 2016, an estimated $63.3M increase.
- Charles Schwab's biggest Q2 2016 reduction was Computer Sciences, cutting an estimated $61.8M.
- Charles Schwab fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $178M.
- Charles Schwab's ten largest holdings make up 14% of its $80B portfolio in Q2 2016.
- Charles Schwab opened 178 new positions and closed 137 in Q2 2016.
- Charles Schwab's portfolio value rose 5% quarter-over-quarter to $80B.
Based on Charles Schwab's 13F filing for Q2 2016, filed 15 Aug 2016.